Differential regulation of cytokine translation by the PI3K/Akt/mTOR pathway

被引：0
|
作者：
Schaeffer, V. [1 ]
Cuschieri, J. [1 ]
Garcia, I. [1 ]
Knoll, M. [1 ]
Arbabi, S. [1 ]
Bulger, E. [1 ]
Maier, R. [1 ]
机构：
[1] Harborview Med Ctr, Seattle, WA 98104 USA
来源：
SHOCK | 2007年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] The pathway of PI3K/AKT/mTOR in pulmonary carcinoids.
    Zhang, Zixuan
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [23] Targeting the mTOR/AKT/PI3K pathway in paediatric malignancies
    Pearson, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S74 - S74
  • [24] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3
  • [25] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [26] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [27] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)
  • [28] PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
    Lisi, Lucia
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2161 - 2163
  • [29] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [30] PI3K/Akt/mTOR pathway as a target for cancer therapy
    Morgensztern, D
    McLeod, HL
    ANTI-CANCER DRUGS, 2005, 16 (08) : 797 - 803
12345